Investigation of ADAMTS-13 levels in patients with COVID-19 infection
COVID-19-associated coagulopathy is still unclear. Based on our data, ADAMTS-13 levels cannot be used as a biomarker to help stratify patients' risks at the time of admission.
Authors
- Serdar Güngör (ORCID: https://orcid.org/0000-0003-2062-2424)
- Sema Yılmaz (ORCID: https://orcid.org/0000-0001-5076-1500)
- Abdurrahman Yılmaz (ORCID: https://orcid.org/0000-0001-8024-8951)
- Songül Doğanay (ORCID: https://orcid.org/0000-0002-1730-1331)
- Arzu Şahin (ORCID: https://orcid.org/0000-0002-8789-4582)
- Soycan Mızrak (ORCID: https://orcid.org/0000-0003-0287-9402)
- Hüseyin Haydar Kutlu
Institutions
- Sakarya University (TR)
- Bilecik Şeyh Edebali Üniversitesi (TR)
- Usak University (TR)
Publication Details
- Journal
- The Journal of Infection in Developing Countries
- Published
- 2024-09-30
- DOI
- https://doi.org/10.3855/jidc.19439
- Citations
- 1
- Primary Topic
- Neuropeptides and Animal Physiology
- Type
- article
- Field-Weighted Citation Impact
- 0.27